[HTML][HTML] Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis

D Li, M Sun, J Zhang, C Zhang, L Deng, H Jiang - Thrombosis Research, 2022 - Elsevier
Background Anticoagulation is important for extracorporeal membrane oxygenation
(ECMO). Heparin is widely used; however, in some cases, it is not suitable for patients …

Updates in anticoagulation therapy monitoring

HL McRae, L Militello, MA Refaai - Biomedicines, 2021 - mdpi.com
In the past six decades, heparin and warfarin were the primary anticoagulants prescribed for
treatment and prophylaxis of venous thromboembolism worldwide. This has been …

Evaluation of bivalirudin as an alternative to heparin for systemic anticoagulation in pediatric extracorporeal membrane oxygenation

M Hamzah, AM Jarden, C Ezetendu… - Pediatric Critical Care …, 2020 - journals.lww.com
Objectives: Heparin is the universal anticoagulant for patients receiving extracorporeal
membrane oxygenation support. However, heparin has many disadvantages, especially in …

Argatroban and bivalirudin for perioperative anticoagulation in cardiac surgery

A Koster, D Faraoni, JH Levy - Anesthesiology, 2018 - pubs.asahq.org
Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery |
Anesthesiology | American Society of Anesthesiologists Skip to Main Content Advertisement …

Snake venoms in diagnostic hemostasis and thrombosis

GW Moore - Seminars in thrombosis and hemostasis, 2022 - thieme-connect.com
Snake venoms have evolved primarily to immobilize and kill prey, and consequently, they
contain some of the most potent natural toxins. Part of that armory is a range of hemotoxic …

Integration of fluorescence and MALDI imaging for microfluidic chip-based screening of potential thrombin inhibitors from natural products

XN Wang, Y Song, W Tang, P Li, B Li - Biosensors and Bioelectronics, 2023 - Elsevier
The microfluidic technology provides an ideal platform for in situ screening of enzyme
inhibitors and activators from natural products. This work described a surface-modified ITO …

The changing landscape of anticoagulation in pediatric extracorporeal membrane oxygenation: use of the direct thrombin inhibitors

C Neunert, M Chitlur, CH Van Ommen - Frontiers in Medicine, 2022 - frontiersin.org
Bleeding and thrombosis frequently occur in pediatric patients with extracorporeal
membrane oxygenation (ECMO) therapy. Until now, most patients are anticoagulated with …

Ecarin based coagulation testing

RC Gosselin, J Douxfils - American Journal of Hematology, 2020 - Wiley Online Library
Ecarin is derived from venom of Echis carinatus, and will activate prothrombin into
meizothrombin which will then cleave fibrinogen to result in clot formation. Ecarin based …

Bivalirudin may reduce the need for red blood cell transfusion in pediatric cardiac patients on extracorporeal membrane oxygenation

DS Machado, C Garvan, J Philip, D Harrington… - ASAIO …, 2021 - journals.lww.com
We retrospectively compared anticoagulation with heparin and bivalirudin for 32
consecutive children under 18 years old during extracorporeal membrane oxygenation …

International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of …

I Mackie, A Casini, M Pieters, R Pruthi… - … journal of laboratory …, 2024 - Wiley Online Library
This guidance was prepared on behalf of the International Council for Standardisation in
Haematology (ICSH) by an international working group of clinicians and scientists. The …